• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Kareo Acquires RPA-Powered Medical Billing Provider PatientlySpeaking

Share:

August 16, 2021

What You Should Know:

– Kareo, a provider of cloud-based clinical and business management software solutions for independent healthcare practices and billing companies, today announced the acquisition of PatientlySpeaking, a process automation technology company for billing companies and medical practices.

– Together with Kareo’s intuitive billing platform, PatientlySpeaking provides an integrated data connection for billing companies and medical practices to automate redundant daily tasks with the power of robotic process automation (RPA) bots. With those tasks out of the way, billers are free to focus on managing their business and being a valued resource for their practices.

Source: Hitconsultant

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Led by Mount Sinai, Trellus Health Nabs $5M for Precision Platform for Complex Chronic ConditionsLed by Mount Sinai, Trellus Health Nabs $5M for Precision Platform for Complex Chronic Conditions
  • American Cancer Society and Color Health Partner to Provide Free Lung Cancer ScreeningAmerican Cancer Society and Color Health Partner to Provide Free Lung Cancer Screening
  • Confluent Announces Significant Investment in ATI Nitinol Melt Expansionconfluent Becomes ATI’s Fulfillment Partner for Medical NitinolConfluent Announces Significant Investment in ATI Nitinol Melt Expansionconfluent Becomes ATI’s Fulfillment Partner for Medical Nitinol
  • Almirall Enters Into An Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical DermatologyAlmirall Enters Into An Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology
  • Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics
  • Schweiger Dermatology Group Announces Acquisition Of Dermatology & Skin Surgery Center, With Locations In Chester County, PennsylvaniaSchweiger Dermatology Group Announces Acquisition Of Dermatology & Skin Surgery Center, With Locations In Chester County, Pennsylvania
  • Covid-19 Alert and Warning Apps to Protect Lives and Livelihoods, says European CommissionCovid-19 Alert and Warning Apps to Protect Lives and Livelihoods, says European Commission
  • BioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple SclerosisBioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple Sclerosis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications